FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

49616005: Monoclonal antibody (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
82640015 Monoclonal antibody en Synonym Active Entire term case insensitive SNOMED CT core module
787314018 Monoclonal antibody (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3779819014 Monoclonal protein en Synonym Active Entire term case insensitive SNOMED CT core module
3779820015 Monoclonal immunoglobulin en Synonym Active Entire term case insensitive SNOMED CT core module


150 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Monoclonal antibody Is a Non-organ specific antibody false Inferred relationship Existential restriction modifier
Monoclonal antibody Is a Antibody true Inferred relationship Existential restriction modifier
Monoclonal antibody Is a Monoclonal immunoglobulin false Inferred relationship Existential restriction modifier
Monoclonal antibody Is a Drug or medicament true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Sylvant 100mg powder for concentrate for solution for infusion vials (EUSA Pharma (UK) Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Obinutuzumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Obinutuzumab 1g/40ml solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Gazyvaro 1000mg/40ml concentrate for solution for infusion vials (Roche Products Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Ramucirumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Ramucirumab 100mg/10ml solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Ramucirumab 500mg/50ml solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Cyramza 500mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Cyramza 100mg/10ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Secukinumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Secukinumab 150mg/1ml solution for injection pre-filled disposable devices Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Secukinumab 150mg/1ml solution for injection pre-filled syringes Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Cosentyx 150mg/1ml solution for injection pre-filled pens (Novartis Pharmaceuticals UK Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Cosentyx 150mg/1ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Pembrolizumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Pembrolizumab 50mg powder for solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Keytruda 50mg powder for concentrate for solution for infusion vials (Organon Pharma (UK) Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Evolocumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Evolocumab 140mg/1ml solution for injection pre-filled disposable devices Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Evolocumab 140mg/1ml solution for injection pre-filled syringes Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Repatha SureClick 140mg/1ml solution for injection pre-filled disposable devices (Amgen Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Repatha 140mg/1ml solution for injection pre-filled syringes (Amgen Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Ustekinumab 90mg/1ml solution for injection pre-filled syringes Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Stelara 90mg/1ml solution for injection pre-filled syringes (Janssen-Cilag Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Alirocumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Alirocumab 150mg/1ml solution for injection pre-filled disposable devices Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Alirocumab 75mg/1ml solution for injection pre-filled disposable devices Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Praluent 75mg/1ml solution for injection pre-filled pens (Sanofi) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Praluent 150mg/1ml solution for injection pre-filled pens (Sanofi) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Idarucizumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Idarucizumab 2.5g/50ml solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Praxbind 2.5g/50ml solution for infusion vials (Boehringer Ingelheim Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Mepolizumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Mepolizumab 100mg powder for solution for injection vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Nucala 100mg powder for solution for injection vials (GlaxoSmithKline UK Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Elotuzumab Is a False Monoclonal antibody Inferred relationship Existential restriction modifier
Necitumumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Necitumumab 800mg/50ml solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Portrazza 800mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Ixekizumab Is a False Monoclonal antibody Inferred relationship Existential restriction modifier
Gemtuzumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Gemtuzumab 5mg powder for solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Mylotarg 5mg powder for solution for infusion vials (Imported (United States)) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Elotuzumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Ixekizumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Elotuzumab 400mg powder for solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Ixekizumab 80mg/1ml solution for injection pre-filled disposable devices Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Ixekizumab 80mg/1ml solution for injection pre-filled syringes Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Elotuzumab 300mg powder for solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Taltz 80mg/1ml solution for injection pre-filled syringes (Eli Lilly and Company Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Taltz 80mg/1ml solution for injection pre-filled pens (Eli Lilly and Company Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Empliciti 400mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Empliciti 300mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Daratumumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Daratumumab 100mg/5ml solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Daratumumab 400mg/20ml solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Darzalex 100mg/5ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Darzalex 400mg/20ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Ustekinumab 130mg/26ml solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Stelara 130mg/26ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Olaratumab Is a False Monoclonal antibody Inferred relationship Existential restriction modifier
Reslizumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Reslizumab 100mg/10ml solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Cinqaero 100mg/10ml concentrate for solution for infusion vials (Teva UK Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Olaratumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Olaratumab 500mg/50ml solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Lartruvo 500mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Pembrolizumab 100mg/4ml solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Keytruda 100mg/4ml concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Bezlotoxumab Is a False Monoclonal antibody Inferred relationship Existential restriction modifier
Bezlotoxumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Bezlotoxumab 1g/40ml solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Zinplava 1g/40ml concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Atezolizumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Atezolizumab 1.2g/20ml solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Tecentriq 1200mg/20ml solution for infusion vials (Imported (United States)) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Olaratumab 190mg/19ml solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Lartruvo 190mg/19ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Inotuzumab ozogamicin Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Inotuzumab ozogamicin 1mg powder for solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Besponsa 1mg powder for solution for infusion vials (Pfizer Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Brodalumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Brodalumab 210mg/1.5ml solution for injection pre-filled syringes Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Kyntheum 210mg/1.5ml solution for injection pre-filled syringes (LEO Pharma) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Portrazza 800mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Sarilumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Sarilumab 150mg/1.14ml solution for injection pre-filled disposable devices Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Sarilumab 150mg/1.14ml solution for injection pre-filled syringes Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Sarilumab 200mg/1.14ml solution for injection pre-filled disposable devices Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Sarilumab 200mg/1.14ml solution for injection pre-filled syringes Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Kevzara 150mg/1.14ml solution for injection pre-filled syringes (Sanofi Genzyme) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Kevzara 200mg/1.14ml solution for injection pre-filled syringes (Sanofi Genzyme) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Kevzara 150mg/1.14ml solution for injection pre-filled pens (Sanofi Genzyme) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Kevzara 200mg/1.14ml solution for injection pre-filled pens (Sanofi Genzyme) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Reslizumab 25mg/2.5ml solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Tecentriq 1200mg/20ml concentrate for solution for infusion vials (Roche Products Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Cinqaero 25mg/2.5ml concentrate for solution for infusion vials (Teva UK Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Cosentyx 150mg/1ml solution for injection pre-filled syringes (Novartis Pharmaceuticals UK Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier
Avelumab Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Avelumab 200mg/10ml solution for infusion vials Has active ingredient False Monoclonal antibody Inferred relationship Existential restriction modifier
Bavencio 200mg/10ml concentrate for solution for infusion vials (Merck Serono Ltd) Has active ingredient True Monoclonal antibody Inferred relationship Existential restriction modifier

Start Previous Page 4 of 5 End


This concept is not in any reference sets

Back to Start